Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that management will present at the TD Cowen 45th Annual Health Care ...

Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual ...

AbbVie will participate in the TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025. Management will participate in a fireside chat at 8:10 a.m. Central time. A live audio webcast ...

Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...

If you get six or more cold sores per year, your doctor may recommend something called suppressive antiviral therapy, which ...